IMed Consultancy’s new free whitepaper, “PMS from pain to potential: more than just ticking a box”, reveals how to transform gruelling PMS procedures into commercial benefit.
With evolving regulatory requirements such as the EU MDR 2017/745, EU IVDR 2017/746, and the UK PMS Statutory Instrument (SI), compliance has never been more demanding. However, businesses can leverage PMS to, for example:
- Reduce their operational burden (expediting literature searches and performance evaluations).
- Protect patient safety by proactively identifying emerging risks.
- Gain commercial advantage by uncovering new markets, applications, and user demographics.
- Support product innovation through data-driven improvements and claim substantiation.
Jonathan Ripley, Managing Director at IMed Consultancy, said:
“The evolution of PMS confirms that compliance can be a strategic opportunity. By adopting a comprehensive, cyclical approach to PMS, manufacturers can not only ensure patient safety but also streamline operations, enhance product development and explore new international markets.”
The new whitepaper is available to download free of charge here.
Provided by Medilink Midlands Member IMed Consultancy.
